NewsRelease
BiotechSupport Group presented 2 posters at the ASMS 2021 Conference on MassSpectrometry & Allied Topics
MONMOUTHJUNCTION, NJ,December1, 2021 -- Biotech Support Group and joint collaborators presentedtwo posters at the ASMS 2021 Conference, in Philadelphia PA, Oct 31 –Nov. 4, 2021.The posters were:
APreliminary Investigation Using Targeted LC-MS Proteomic MethodsDemonstrates Unique Serum Profiles of Hospitalized SARS-CoV-2Patients
DouglasD Fraser1;Haiyan Zheng2;Swapan Roy3; MattKuruc3;Amenah Soherwardy2;Devjit Roy4;Sowmya Avadhani 3
1LawsonResearch Institute, London, Ontario; 2RutgersUniversity Proteomics Center, Piscataway, New Jersey; 3BiotechSupport Group LLC, Monmouth Junction, NJ; 4NathanLittauer Hospital, Gloversville, New York CorrespondingAuthor:[email protected]
Clickimage to download
Briefdescription: For serum samples, targeted LC-MS is challenging, mainlydue to the presence of highly abundant proteins. So it becomescritical to pair target peptides to sample depletion methods to bestestablish differentiated profiles between samples. In thispreliminary investigation, we use unique methods described here tocharacterize the functionality of the innate immune response inhospitalized Covid-19 patients, more precisely than current methods.
High-throughput,Automated INTip™ SPE Combined with AlbuSorb™ Products forEfficient Albumin and Albumin/IgG Depletion
MatthewFitts 1;William E. Kemnitzer 1;Paul Meeh 1; MattKuruc2;Swapan Roy 2;Sowmya Avadhani 2
1DPXTechnologies, Columbia, SC; 2BiotechSupport Group LLC, Monmouth Junction, NJ Corresponding Author:[email protected]
Clickimage to download
Briefdescription: We report here new methods to incorporate beads fordepletion of Albumin, IgG and Hemoglobin, into pipette tips known asXTRaction tips or XTR tips. The XTR tip format improves ease of useand scalability to process multiple samples in parallel, utilizing96-well plates and automated liquid handlers. The incorporated BSGbeads are consumable, and not derived from immuno-affinity.
“Thesetwo posters highlight the value of collaborative partners jointlyworking to commercialize new methods and biomarkers using novelproteomic sample prep products. The first demonstrates how we canadapt LC-MS to study the functionality of a most important regulatingfamily of proteins - the Serpins, as they serve as central controlwithin the innate immune response. The second demonstrates ourcommitment to high-throughput and automation for clinical proteomics. It is very exciting to share these developments with a dedicatedgroup at the forefront of mass spectrometry research”, states Dr.Swapan Roy, Ph.D., President and Founder of Biotech Support Group.
Formore information on BSG & Lawson Health Research InstituteCollaborative Research Agreement, see our joint press release:
https://www.biotechsupportgroup.com/Articles.asp?ID=612
Formore information on INTip™ SPE and BSG products, see our jointpress release:https://www.biotechsupportgroup.com/Articles.asp?ID=615
Formore information on the BSG complete line of Albumin& IgG Removal products,visit: https://www.biotechsupportgroup.com/Albumin-Removal-s/307.htm
Formore information on the BSG complete line of HemoglobinRemovalproducts, visit:
https://www.biotechsupportgroup.com/Hemoglobin-Removal-s/312.htm
AboutBiotech Support Group LLC
Convergingwith cultural and technological disruptions forthcoming inhealthcare, Biotech Support Group develops methods for cost effectiveand efficient sample prep essential for these expanding markets.Following a tiered business strategy, the company continues itsgrowth in the consumable research products area supporting therapidly expanding installation of LC-MS instrument and computationalinfrastructure. For this market, key products include: AlbuVoid™and AlbuSorb™ for albumin depletion, Cleanascite™ for lipidadsorption, and HemogloBind™ and HemoVoid™ for hemoglobinremoval. From these innovations, the company has acquiredknowledgebase and biomarker intellectual property assets that supportdiscoveries of protein markers from blood, with special emphasis onearly detection and personalized medical decisions for cancerpatients. For more information, gotohttps://www.biotechsupportgroup.com
ForBusiness Development, contact:MatthewKuruc 732-274-2866[email protected]